Table 1.
Group | Subgroup | Count (N = 804) | Frequency |
---|---|---|---|
Sex | |||
Male | 312 | 0.39 | |
Female | 492 | 0.61 | |
Agea | |||
7-9 | 19 | 0.02 | |
10-19 | 189 | 0.23 | |
20-29 | 170 | 0.21 | |
30-39 | 173 | 0.22 | |
40-49 | 159 | 0.20 | |
50-78 | 94 | 0.12 | |
Age at onset of OC symptoms | |||
5-9 | 518 | 0.64 | |
10-19 | 237 | 0.30 | |
20-44 | 118 | 0.06 | |
SRI responseb | |||
“No response” | 290 | 0.36 | |
“Response” | 514 | 0.64 |
Age unknown for 5 participants.
“Couldn't tolerate” and “Unknown” were excluded from data analysis.